Literature DB >> 1792934

Interaction between carbamazepine and fluvoxamine.

J Fritze1, B Unsorg, M Lanczik.   

Abstract

In 3 patients the addition of fluvoxamine to a constant dosage of carbamazepine (CZP) caused a substantial rise of plasma CZP accompanied by symptoms of intoxication. As this drug combination may occur increasingly in the future, this probably pharmacokinetic interaction is of practical relevance.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1792934     DOI： 10.1111/j.1600-0447.1991.tb03200.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN： 0001-690X            Impact factor:   6.392


  22 in total

Review 1.  Pharmacokinetics of haloperidol: an update.

Authors:  S Kudo; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 2.  Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Authors:  E Spina; F Pisani; E Perucca
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 3.  Clinically significant drug interactions with antidepressants in the elderly.

Authors:  Edoardo Spina; Maria Gabriella Scordo
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 4.  Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Authors:  P Baumann
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

5.  Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients.

Authors:  S Härtter; H Wetzel; E Hammes; C Hiemke
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Serotonin mediated cluster headache, trigeminal neuralgia, glossopharyngeal neuralgia, and superior laryngeal neuralgia with SAD chronicity.

Authors:  J L Weiss; K L Weiss; S M Benecke
Journal:  Child Psychiatry Hum Dev       Date:  2001

7.  Non-competitive inhibition of clomipramine N-demethylation by fluvoxamine.

Authors:  S Härtter; M Arand; F Oesch; C Hiemke
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

Review 8.  Fluvoxamine. A review of global drug-drug interaction data.

Authors:  W Wagner; E W Vause
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

Review 9.  Overview of the pharmacokinetics of fluvoxamine.

Authors:  J van Harten
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

Review 10.  Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.

Authors:  M I Wilde; G L Plosker; P Benfield
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.